皓宸医疗(002622) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 29,544,061.68, down 74.64% year-on-year, and CNY 97,172,107.69 for the year-to-date, down 66.03% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 215,395.72, a decrease of 98.78% year-on-year, with a year-to-date net loss of CNY 14,487,379.75, down 174.06%[7] - Basic and diluted earnings per share were CNY 0.0003, a decrease of 98.58% year-on-year, with a year-to-date loss per share of CNY -0.0172, down 173.82%[7] - The net profit for the period was a loss of CNY 14,442,647.78, compared to a profit of CNY 42,786,097.31 in the previous year[52] - The net profit for the third quarter of 2019 was CNY 16,084,445.30, compared to a net loss of CNY 19,540,657.06 in the same period last year, indicating a significant turnaround[56] Cash Flow - The net cash flow from operating activities was CNY 3,166,263.33, down 92.20% year-on-year, and CNY -16,958,299.70 for the year-to-date, down 148.16%[7] - The cash flow from operating activities showed a net outflow of CNY 16,958,299.70, contrasting with a net inflow of CNY 35,209,340.95 in the same quarter last year[61] - The net cash flow from operating activities decreased by 52.17 million RMB, reflecting a significant decline in sales collections compared to the previous year[17] - The cash inflow from investment activities was 190,100,572.92 CNY, while cash outflow was 214,565,733.11 CNY, leading to a net cash flow of -24,465,160.19 CNY[64] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,786,585,561.48, a decrease of 4.52% compared to the end of the previous year[7] - The total liabilities decreased from ¥526,918,994.40 to ¥496,827,393.54, representing a reduction of about 5.7%[36] - The company's cash and cash equivalents dropped significantly from ¥99,804,517.63 to ¥32,921,079.69, a decline of approximately 67%[33] - The total current liabilities were CNY 848,234,072.86, including short-term borrowings of CNY 130,000,000.00[74] Shareholder Information - The total number of shareholders at the end of the reporting period was 63,895, with the largest shareholder holding 23.81% of the shares[10] - The largest shareholder, Guangzhou Huiyin Rifen Investment Partnership, held 200,000,000 shares[12] Operational Metrics - The operating costs decreased by 76.66%, resulting in a reduction of 120.88 million RMB, in line with the decrease in operating revenue[17] - The total operating costs amounted to CNY 40,974,486.50, a decrease from CNY 130,501,883.28 year-over-year[43] - The total operating revenue for the first three quarters was CNY 97,172,107.69, a decrease of 66.0% compared to CNY 286,013,061.43 in the same period last year[50] Non-Operating Income and Expenses - Non-operating income included government subsidies of CNY 1,245,941.00, which are closely related to the company's business[8] - The company incurred tax expenses of CNY 3,360,879.35, compared to a tax benefit of CNY -9,013,316.06 in the previous year[52] Compliance and Governance - The company reported no non-compliance with external guarantees during the reporting period[25] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[26] - The company has not undergone an audit for the third quarter report[76] - The report indicates a significant focus on improving financial reporting and compliance with new regulations[76]